UVEAL MELANOMA, METASTATIC
Clinical trials for UVEAL MELANOMA, METASTATIC explained in plain language.
Never miss a new study
Get alerted when new UVEAL MELANOMA, METASTATIC trials appear
Sign up with your email to follow new studies for UVEAL MELANOMA, METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug MBS8(1V270) enters human testing for advanced cancers
Disease control Recruiting nowThis early-stage study tests a new drug called MBS8(1V270) in about 106 people with advanced solid tumors that have not responded to standard treatments. The main goal is to check safety and find the best dose. Researchers will also look for early signs that the drug shrinks tumo…
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1 • Sponsor: MonTa Biosciences ApS • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New combo therapy aims to boost immune attack on rare eye cancer
Disease control Recruiting nowThis early-phase study tests whether adding roginolisib to the standard drug tebentafusp is safe and tolerable for people with advanced uveal melanoma, a rare eye cancer that has spread. Only 8 adults who are already on tebentafusp and have a specific genetic marker (HLA-A*02:01)…
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
New drug targets Hard-to-Treat melanoma in early trial
Disease control Recruiting nowThis early-phase trial tests an investigational drug called [225Ac]Ac-A9-3408 in 50 adults with melanoma that has spread or cannot be removed by surgery. The main goals are to find the safest dose and understand side effects. Participants receive the drug once every 6 weeks for u…
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1 • Sponsor: Alpha-9 Oncology USA Inc. • Aim: Disease control
Last updated May 05, 2026 11:56 UTC
-
New pill shows promise for rare eye cancer that spreads
Disease control Recruiting nowThis study tests an experimental drug called NBM-BMX for people with metastatic uveal melanoma, a rare eye cancer that has spread to other parts of the body. The goal is to find the best dose, check for side effects, and see if the drug can shrink tumors or slow the cancer. About…
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated May 01, 2026 15:59 UTC